dioxiram has been researched along with N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide in 1 studies
| Studies (dioxiram) | Trials (dioxiram) | Recent Studies (post-2010) (dioxiram) | Studies (N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide) | Trials (N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide) | Recent Studies (post-2010) (N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 6 | 0 | 1 |
| Protein | Taxonomy | dioxiram (IC50) | N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide (IC50) |
|---|---|---|---|
| glutathione S-transferase omega-1 isoform 1 | Homo sapiens (human) | 0.028 | |
| Glutathione S-transferase omega-1 | Homo sapiens (human) | 0.028 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baell, JB; Board, PG; Casarotto, MG; Dahlin, JL; Oakley, AJ; Xie, Y | 1 |
1 review(s) available for dioxiram and N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide
| Article | Year |
|---|---|
Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example.
Topics: Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fluorescence Polarization; Glutathione Transferase; Humans | 2018 |